Nobody really explains the difference when the test gets ordered. A tube gets handed over, a form gets signed, and most patients assume one sample is more or less the same as another. It isn't. The choice between saliva and blood for cancer genetic testing is not arbitrary, and understanding what each one actually measures changes how you read the results.
Getting DNA from the body
Every cell in the body carries a complete copy of your DNA. Saliva contains cells shed from the lining of the mouth. Blood contains white blood cells. Both are reliable sources of genetic material for germline testing — the kind that looks at mutations you were born with and carry in every cell. The collection method changes. Nothing fundamental about what gets tested changes.
Saliva testing
Saliva kits are what most direct-to-consumer genetic companies use. You spit into a tube, seal it, and mail it off—no needle, no clinic visit, no appointment needed. For people who are needle-averse or live far from testing facilities, it removes a real barrier.
The limitation is contamination. Food, drink, smoking, and even brushing teeth too close to collection can introduce foreign DNA into the sample and affect quality. Most kits ask for nothing by mouth for at least thirty minutes beforehand. Patients with certain oral conditions or dry mouth, which can be a side effect of cancer treatment, sometimes produce samples that don't meet the quality threshold and have to retest.
Blood testing
Blood draws happen in a clinic. A small tube of blood gets sent to a laboratory where white blood cells provide the DNA. The sample quality is generally more consistent and less vulnerable to contamination than saliva. For clinical genetic testing ordered through an oncologist or genetic counsellor, blood is still the more common method.
The barrier is access. Getting to a clinic, having blood drawn, navigating the referral — for some patients, that process takes longer than it should. Both have the same result
Here's something that confuses people. Saliva and blood tests for germline mutations — inherited ones present from birth — should produce the same result. They're reading the same DNA from different cell sources. If a BRCA2 mutation is present, it shows up in both.
The situation gets more complicated if someone has had a bone marrow transplant. After a transplant, the blood contains the donor's DNA, not the patient's. Testing blood in that case gives the donor's genetic profile, not the patient's. Saliva testing avoids that problem entirely because mouth cells come from the patient's own tissue.
Choosing the right one
For standard inherited cancer risk testing, such as BRCA, Lynch syndrome, and similar, either method works. The decision usually comes down to access, convenience, and what the testing provider offers.
For anyone post-transplant, saliva is the more reliable choice. For anyone with concerns about oral health affecting sample quality, blood is cleaner.
Ask whoever ordered the test which method they recommend for your specific situation. That question takes thirty seconds and removes any uncertainty about whether the result you get back actually reflects your genetics.